Proven Clinical Benefits

2004
Results of a US clinical study published in the June 2004 issue of the Archives of Otolaryngology, an American Medical Association publication, reported that patients who used the Meniett device for Ménière's Disease experienced significantly less severe vertigo, fewer days with vertigo, and fewer days missed from work due to the disease compared to patients in the control group. There were no complications from using the device.The randomized, placebo-controlled, double-blind, multicenter trial evaluated 62 people for four months. Each had established Ménière's Disease that was unresponsive to medical therapy.⁵

2002
Ten patients were evaluated who had failed medical/dietary treatment. With an average of eight months treatment, vertigo was completely controlled in nine of 10 patients using the Meniett device, and there was a 50 percent reduction in vertigo in the tenth case. Most patients noted symptoms recurred when they did not use the Meniett device as prescribed or their ventilation tube became blocked.³

2001
This two-year follow-up study with the Meniett device involved 37 Ménière's Disease patients. Thirty-one of the 37 patients had failed medical treatment prior to enrollment. Study results showed that the Meniett treatment significantly improved vertigo symptoms and functionality levels in 92 percent of patients. No side effects related to the treatment were reported.⁴ 

2000
In a two-week, randomized, placebo-controlled, multicenter trial, 31 patients with advanced symptoms of Ménière's Disease experienced relief of vertigo after short-term pressure treatments using the Meniett device. The 25 patients who used a placebo device had no improvement.²

1997
A prospective, randomized, placebo-controlled study of 39 Ménière's Disease patients showed improvement in inner ear cochlear function immediately after exposure to low-pressure pulses in the middle ear.¹